Does Dr. JULIE AMORUSO have financial conflicts of interest?

Dr. JULIE AMORUSO (FNP PMHNP) has received a total of $257 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $257 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JULIE AMORUSO?

According to CMS Open Payments data, Dr. JULIE AMORUSO received funding from ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .) ($80), TEVA PHARMACEUTICALS USA ($65), and LUNDBECK ($47).

Does Dr. JULIE AMORUSO receive research grants or speaking fees?

Dr. JULIE AMORUSO has received $257 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JULIE AMORUSO

FNP PMHNPReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: FOLSOM, CA 95630

NPI Number: 1548600117

LIFETIME INDUSTRY VALUE

$257

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AMORUSO is a verified Nurse Practitioner, Family practitioner based in FOLSOM, CA.

Between 2021 and 2025, Dr. AMORUSO had an overall industry promotional and research financial footprint of $257 as recorded in the federal CMS Open Payments database.

$257 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AMORUSO's primary funding source is ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .), which accounts for $80 (representing 31.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .)

Rank 1

$80

31.3%

TEVA PHARMACEUTICALS USA

Rank 2

$65

25.4%

LUNDBECK

Rank 3

$47

18.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.